Abstract
Purpose
The sentinel lymph node (SLN) is thought to reflect the metastatic status of the remaining axillary lymph nodes in patients with breast cancer. We used technetium-99m-labeled tin colloids to identify SLN. The efficacy and significance of SLN identification using this method were investigated in terms of number, size, location, and tumor metastasis. The efficacy of the emulsion charcoal injection method for the intraoperative visible identification of SLN was also evaluated.
Methods
Twenty-five patients with invasive breast cancer were studied. Under ultrasonographic guidance, technetium-99m-labeled tin colloid particles (3 ml) were injected into 3 sites around the tumor within 3 mm of the margin or into the wall of the excisional biopsy cavity 2 hours before surgery. At surgery, just before the incision, an emulsion of charcoal particles (2.5 ml) was injected into 3 sites of the breast parenchyma surrounding the tumor. All patients underwent mastectomy with axillary dissection to the infraclavicular region. The radioactivity of each dissected lymph node was measured. All axillary specimens were processed in individual blocks for permanent section histopathologic evaluation with H &E.
Results
SLN were defined as lymph nodes with 100 000 or more counts per minute (cpm) in radioactivity after injection of labeled tin colloids. In all 25 patients, SLN were identified (mean, 1.9 SLN/patient; range,l-4). Since the mean uptake in SLN was 383 124 cpm, but only 884 cpm in non-SLN nodes, discrimination between SLN and non-SLN nodes was easy. Clearly visible lymph nodes with charcoal staining accounted for 83.3% of all SLN, although 21.3% of non-SLN also stained. SLN were located only in the axillary region, but there were no other specific features in the location or size of SLN. The SLN were metastatic in 10 of the 25 patients: in 4, the SLN were the only metastatic nodes whereas in the remaining 6 patients, other axillary nodes were also positive. Fifteen patients with no metastasis in SLN had no tumor involvement in any other lymph nodes. There were no skip metastases.
Conclusion
SLN identified with labeled tin colloids have clinical value in predicting the metastatic status of the remaining axillary lymph nodes in breast cancer.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- SLN:
-
Sentinel lymph node(s)
- ALND:
-
Axillary lymph node dissection
- cpm:
-
Counts per minute
- H & E:
-
Hematoxylin and eosin staining
- n.s.:
-
No significance
- SLND:
-
Sentinel lymph node dissection
References
Wazer DE, Erban JK, Robert NJ,ea al: Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection.Cancer 74:878–883, 1994.
Silverstein MJ, Giersen ED, Waisman JR,ea al: Axillary lymph node dissection for T1a carcinoma; Is it indicated?Cancer 73:664–667, 1994.
Haffty BG, Ward B, Pathare P,ea al: Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer.J Clin Oncol 15:691–700, 1997.
Recht A, Houlihan MJ: Axillary lymph nodes and breast cancer; A review.Cancer 76:1491–1512, 1995.
Copeland EM: Is axillary dissection necessary for T1 carcinoma of the breast?J Am Coll Surg 184:397–398, 1997.
Kissin MW, Querci della Rovere G, Easton D,ea al: Risk of lymphedema following the treatment of breast cancer.Br J Surg 73:580–585, 1986.
Fisher B.Wolmark N, Bauer M,ea al: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast.Surg Gynecol Obstet 152:765–772, 1981.
Moffat F, Senofsky G, Davis K,ea al: Axillary node dissection for early breast cancer; Some is good, but all is better.J Surg Oncol 51:8–13, 1992.
Cabanas RM: An approach for the treatment of penile carcinoma.Cancer 39:456–466, 1977.
Morton D, Wen D, Cochran A: Management of earlystage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy; An alternative to routine elective lymphadenectomy or “watch and wait”.Surg Oncol Clin N Am 1:247–259, 1992.
Morton D, Wen D, Wong J,ea al: Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 127:392–399, 1992.
Van der Veen H, Hoekstra OS, Paul MA,ea al: Gamma-probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy.Br J Surg 81:1769–1770, 1994.
The Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, 12th ed, Kanehara, Tokyo, ppl-18, 1996.
Krag DN, Weaver DL, Alex C,ea al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.Surg Oncol 2:335–340, 1993.
Albertini JA, Lyman GH, Cox C,ea al: Lymphatic mapping and sentinel node biopsy in the patients with breast cancer.JAMA 276:1818–1822, 1996.
Guiliano AE, Dale PS, Turner RB,ea al: Improved axillary staging of breast cancer with sentinel lymphadenectomy.Ann Surg; 222:394–401, 1995.
Veronesi U, Paganelli G, Galimberti V,ea al: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.Lancet 349:1864–1867, 1997.
Pijpers R, Meijer S, Hoekstra OS,ea al: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.J Nucl Med 38:366–368, 1997.
Alazraki N, Eshima D, Eshima L,ea al: Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers.Semin Nucl Med 27:55–67, 1997.
Fujii K, Sawai K, Shimotsuma M,ea al: Study of lymphatic flow of mammary gland by application of activated carbon emulsion (CH44).J Jpn Soc Cancer Ther 21:96–102, 1986.
Veronesi U, Luini A, Galimberti V,ea al: Extent of metastatic axillary involvement in 1446 cases of breast cancer.Eur J Surg Oncol 16:127–133, 1990.
Turner RR, Ollila DW, Krasne DL,ea al: Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.Ann Surg 226:271–278, 1997.
Noguchi M, Kawahara F, Tsugawa K,ea al: Sentinel lymphadenectomy in breast cancer; An alternative to routine axillary dissection.Breast Cancer 5:1–6, 1998.
Author information
Authors and Affiliations
About this article
Cite this article
Sato, K., Hiraide, H., Uematsu, M. et al. Efficacy and Significance of Sentinel Lymph Node Identification with Technetium-99m-labeled Tin Colloids for Breast Cancer. Breast Cancer 5, 389–393 (1998). https://doi.org/10.1007/BF02967436
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02967436